We partnered with community leaders to launch highly effective COVID-19 vaccine clinics to rapidly increase the pace of vaccinations in communities of color in Philadelphia. Learn about the novel no/low-tech strategy we employed to ensure equitable care delivery in NEJM Catalyst.
Did the COVID-19 pandemic change activity among patients most at risk for heart disease?
A study led by researchers at the Nudge Unit revealed that stay-at-home orders put in place during the COVID-19 pandemic were associated with a significant decline in physical activity among adults with elevated risk for major adverse cardiovascular events.
The study's findings suggest that the pandemic could disproportionately reduce physical activity among minority and urban patients, further increasing disparities in preventative health behaviors.
Study shows 60 percent of opioids go unused after common procedures
A study led by researchers at the Center for Digital Health showed that more than half of the opioids prescribed to patients undergoing orthopaedic and urologic surgeries went unused.
The team collected patient-reported data on pain and opioid use through an automated text messaging system and found that most opioids are taken in the first few days and may not be necessary to manage pain even just a week after a procedure.
The results of this study suggest that opportunities exist to tailor opioid prescriptions and reduce excess quantities of opioids prescribed.
How Penn Medicine reimagined breast reconstruction
Penn Medicine's CARe program shifts care for autologous breast reconstruction from a high-touch clinic-based model to a digitally-enabled home-based strategy that ensures a more patient-centric return to independence.
In NEJM Catalyst, CARe's multidisciplinary team describes the iterative design approach they used to transform the recovery process to improve outcomes and quality of life.
Rapid implementation of a saliva-based COVID-19 screening program
Regular COVID-19 testing is a critical component for safe reopening. In a piece for NEJM Catalyst, members of the Nudge Unit team describe the design and implementation of Covid SAFE, a saliva-based SARS-CoV-2 surveillance testing program with automated screening and reporting.